A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Unless otherwise indicated or the context otherwise requires, references to the “Company”, “Aethlon”, “we”, “us” and “our” refer to Aethlon Medical, Inc. Overview and Corporate History We are a medical therapeutic company focused on developing the Hemopurifier® (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In human studies (164 sessions with 38 patients), the Hemopurifier was used safely and demonstrated the potential to remove enveloped viruses. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | - | - | - | - |
| Net Income | -12M | - | -12M | -10M | -7.9M | -6.4M |
| EPS | $-48.01 | $-3,109.60 | $-4,688.00 | $-568.00 | $-520.00 | $-1,496.00 |
| Free Cash Flow | 0 | -10M | -11M | -10M | -6.8M | -5.3M |
| ROIC | -72.2% | - | -74.7% | -78.4% | -66.1% | -49.8% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.16 | 0.16 | 0.14 | 0.15 | 0.00 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -7.4M | -13M | -12M | -10M | -7.9M | -5.9M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -171.6% | - | -74.7% | -78.4% | -83.7% | -67.7% |
| Shares Outstanding | 1M | 0M | 0M | 0M | 0M | 0M |
AETHLON MEDICAL INC passes 0 of 9 quality checks, indicating weak fundamentals.
AETHLON MEDICAL INC (AEMD) has a 5-year average return on invested capital (ROIC) of -67.3%. This is below average and may indicate limited pricing power.
AETHLON MEDICAL INC (AEMD) has a market capitalization of $3M. It is classified as a small-cap stock.
AETHLON MEDICAL INC (AEMD) does not currently pay a regular dividend.
AETHLON MEDICAL INC (AEMD) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
AETHLON MEDICAL INC (AEMD) generated $-10 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
AETHLON MEDICAL INC (AEMD) has a debt-to-equity ratio of 0.16. This indicates a conservatively financed balance sheet.
AETHLON MEDICAL INC (AEMD) reported earnings per share (EPS) of $-3109.60 in its most recent fiscal year.
The Ledger Terminal provides 14 years of financial data for AETHLON MEDICAL INC (AEMD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
AETHLON MEDICAL INC (AEMD) has a book value per share of $178.43, based on its most recent annual SEC filing.